Clinical Research Directory
Browse clinical research sites, groups, and studies.
Commercial Prebiotic Supplement Study
Sponsor: University of Aberdeen
Summary
Previous work in 2015/16 has identified changes in the gut microbiota with prebiotic (Molkosan®) supplement. It report significant changes in metabolic health bio-markers and faecal SCFA profile in 18 health adult subjects consuming 20 ml of product twice a day. Improvement in fasting metabolic parameters was observed flowing the intervention period. A reduction on Total Cholesterol, Glucose, Triglycerides and Insulin was observed. In this study, a lower dose (20ml/d) in subjects with type 2 diabetes will be examed, over an extended period of time (12 week period) to match the profile of the intended consumer and provide preliminary data to support a larger multi-centre trial.
Official title: Effect of Prebiotic in Type 2 Diabetes (Diabetes and Health Study)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2017-05-10
Completion Date
2017-07-18
Last Updated
2026-05-14
Healthy Volunteers
No
Conditions
Interventions
20 ml of prebiotic per day
12 volunteers will take 20ml of prebiotic per day for 12 weeks
Locations (1)
The Rowett Institute, Human Nutrition Unit
Aberdeen, United Kingdom